<DOC>
	<DOC>NCT00544037</DOC>
	<brief_summary>To assess the long-term effects of early therapeutic intervention, i.e. within two years following a first clinical demyelinating event suggestive of MS.</brief_summary>
	<brief_title>BENEFIT Extension Study</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Interferon-beta</mesh_term>
	<mesh_term>Interferon beta-1b</mesh_term>
	<criteria>All patients randomized and treated at least once in study 304747 Medical, psychiatric or other conditions that compromise the patient's ability to understand the purpose of the study</criteria>
	<gender>All</gender>
	<minimum_age>23 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2012</verification_date>
</DOC>